Pharmacy Pearl 11 december 2002
|
A 57 y/o patient with significant renal dysfunction (CrCl < 20
ml/min) and CHF (NYHA category II) needs a loop diuretic because of his fluid
retention. He has no other significant medical history but is severely
allergic to sulfa drugs/sulfonamides (developed interstitial nephritis after
furosemide). The physician asks what other diuretic can we use in this
patient? What is your answer? SELECT here for discussion |
DISCUSSION 11 DECEMBER 2002
|
** This was an actual case ** The traditional answer is ethacrynic acid [Edecrin ®]. This is a non-sulfonamide loop diuretic, usually available as IV and oral forms. The problem with this agent is the oral form is not currently available from the only manufacturer (Merck). There is a very limited supply of the IV form. The best info we have from the manufacturer is there may be some oral forms available in early 2003. There are other loop diuretics such as torsemide, bumetanide but all have warnings or contraindications about using them in patients with allergies/hypersensitivity to sulfonamides. Thiazide diuretics generally don't work in patients with CrCls less than ~30 ml/minute. Metolazone MAY be an option in this patient but is only available in an oral form. (FYI - Metolazone is more effective than other thiazide diuretic but less effective than loop diuretics, maybe due to a more proximal site of action in the nephron). Mercurial diuretics are no longer commercially available and are only of academic interest. Acetazolamide, a carbonic anhydrase inhibitor, has some diuretic effects. It's diuretic effects are rapidly overcome. This would NOT be an option in this patient due to the sulfonamide allergy also. Potassium sparing diuretics (triamterene, spironolactone, amiloride) are rather weak diuretics and probably contraindicated in this patient due to the increased risk of hyperkalemia. Mannitol may be used in early, acute failure but not in generalized edematous states such as CHF. With significant renal dysfunction (as in this patient) the retention of the hypertonic mannitol within the vasculature may cause further volume expansion/fluid retention, worsening CHF and possibly precipitating pulmonary edema. Hemodialysis is an option but usually the final option. This Pearl is meant for academic and educational purposes only. This Pearl is meant to raise important points regarding the safe and cost-effective pharmacotherapy of patients. It is not meant to be the definitive reference for the treatment or prophylaxis of various diseases. Although every effort is taken to ensure this Pearl is correct and factual, errors may occur. The Pharmacoeconomic Center assumes no liability for incorrect information or harm that may occur from the use of the information included in this Pearl. |
![]()